Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
American Aires Inc. is a publicly traded company focused on the development, marketing, and distribution of proprietary electromagnetic field (EMF) modulation technology intended to reduce the potential biological effects of EMF exposure from everyday electronic devices. The company operates at the intersection of consumer wellness, wearable technology, and electromagnetic field mitigation, offering products designed for personal, residential, and commercial use. Its core revenue is derived from the sale of branded EMF modulation devices marketed under the Aires Tech brand.
The company’s primary products include wearable devices, mobile phone accessories, and home or office-based units that incorporate its patented silicon-based resonator technology. These products are sold directly to consumers through e-commerce channels and through select distribution partners. American Aires positions itself as a technology-driven wellness company, emphasizing laboratory testing, intellectual property protection, and regulatory compliance as key differentiators. The company traces its origins to research and commercialization efforts around EMF modulation technology and later became publicly listed to fund product development and global expansion. Certain aspects of the company’s early corporate history and predecessor entities are not consistently detailed across public disclosures; data inconclusive based on available public sources.
Business Operations
American Aires conducts its operations primarily through its wholly owned subsidiary Aires Tech Inc., which is responsible for product development, intellectual property management, marketing, and sales execution. Revenue is generated through direct-to-consumer online sales, wholesale arrangements, and international distributors. The company does not manufacture semiconductors at scale internally; instead, it relies on third-party manufacturing partners while retaining control over design specifications and patented technology.
Operations are largely asset-light, centered on intellectual property, branding, and digital commerce infrastructure. The company holds multiple issued and pending patents related to EMF modulation and signal harmonization technologies. American Aires has reported sales activity in both consumer and enterprise contexts, including pilots or limited deployments in education, transportation, and workplace environments, though the scale and recurrence of these contracts vary by period and are not always disaggregated in public filings.
Strategic Position & Investments
The company’s strategic direction emphasizes global brand expansion, increased scientific validation of its technology, and penetration of new customer segments concerned with EMF exposure. Growth initiatives have included expanded product lines, increased marketing spend, and efforts to enter institutional and enterprise markets. American Aires has also invested in additional laboratory testing and certifications to support product claims and regulatory acceptance.
American Aires’ primary investment focus remains internal, centered on intellectual property development and commercialization rather than a diversified portfolio of external investments. The company does not consistently report large-scale acquisitions; when acquisitions or technology transfers are referenced, they are typically related to intellectual property consolidation within Aires Tech Inc. Public disclosures do not indicate material ownership of unrelated operating subsidiaries or minority stakes in external portfolio companies; data inconclusive based on available public sources.
Geographic Footprint
American Aires is headquartered in North America, with executive management and corporate functions primarily based in Canada, while its public listing and investor base include significant participation from the United States. The company markets and ships products across North America, Europe, Asia-Pacific, and parts of Latin America, primarily through online channels and regional distributors.
International presence is largely commercial rather than operational, with no publicly disclosed foreign manufacturing facilities owned by the company. Market expansion efforts have focused on regions with high smartphone penetration and consumer interest in wellness technologies. While global sales are reported, revenue by specific country or region is not always fully broken out in public filings; data inconclusive based on available public sources.
Leadership & Governance
American Aires is led by a management team with experience in technology commercialization, consumer marketing, and corporate finance. Leadership has articulated a strategic vision centered on making EMF modulation technology widely accessible while supporting its adoption through scientific research, regulatory engagement, and education-driven marketing.
Key executives include:
- Josh Bruni – Chief Executive Officer
- Conrad Grigoriadis – Chief Financial Officer
- Alex Chou – Chief Technology Officer
- Susanne Schnyder – President, Europe
The board of directors oversees corporate governance, capital allocation, and long-term strategy, with an emphasis on intellectual property protection and shareholder value creation. Founder attribution is not consistently stated across public disclosures; data inconclusive based on available public sources.